TY  - JOUR
AU  - Buzzoni,C
AU  - Luján Galán, Marcos
AU  - Zappa,M
PY  - 2015
DO  - 10.1016/j.eururo.2015.02.042
SN  - 0302-2838
UR  - https://hdl.handle.net/20.500.14352/116479
T2  - European Urology
AB  - Background: The European Randomized Study of Screening for Prostate Cancer (ERSPC) has shown a 21% reduction in prostate cancer (PCa) mortality and a 1.6-fold increase in PCa incidence with prostate-specific antigen (PSA)-based screening (at 13 yr of...
LA  - eng
M2  - 885
PB  - Elsevier B.V.
KW  - Metastatic cancer incidence
KW  - Mortality reduction
KW  - PSA
KW  - Prostate screening
TI  - Metastatic prostate cancer incidence and prostate-specific antigen testing: new insights from the european randomized study of screening for prostate cancer.
TY  - journal article
VL  - 68
ER  -